MD Biosciences, Inc.
Preclinical services include efficacy and mode of action studies in the inflammation, immuno-oncology and CNS therapeutics areas. Translational services featuring porcine models and full-service histology/IHC/ISH capabilities bridge the gap between discovery-stage research findings and potential clinical utility, accelerating programs towards their next objectives and milestones. Clinical stage services are focused on biomarker validation laboratory testing and CDx development on multiple platforms, including flow cytometry, multiplexed IHC, proteomics and PCR. Our CRO relationship model allows for transparent sharing of information, coordinated decision-making and a high level of flexibility. We approach each project uniquely as a team-oriented research effort. We host frequent discussions with our Sponsors to determine ultimate study objectives, adapt to new information as it is generated, and provide insight wherever possible.